Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 619Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 8Aptiom

02 5Zebinix

PharmaCompass

01

Brand Name : Aptiom

Eslicarbazepine Acetate

arrow
Fi Europe 2024
Not Confirmed

02

Brand Name : Zebinix

Eslicarbazepine Acetate

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Zebinix

arrow
Fi Europe 2024
Not Confirmed

Eslicarbazepine Acetate

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2020 Revenue in Millions : 63

2019 Revenue in Millions : 58

Growth (%) : 8

blank

03

Brand Name : Aptiom

Eslicarbazepine Acetate

arrow
Fi Europe 2024
Not Confirmed

04

Brand Name : Zebinix

Eslicarbazepine Acetate

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Zebinix

arrow
Fi Europe 2024
Not Confirmed

Eslicarbazepine Acetate

Main Therapeutic Indication : Neurology

Currency : USD

2021 Revenue in Millions : 49

2020 Revenue in Millions : 60

Growth (%) : -12

blank

05

Brand Name : Aptiom

Eslicarbazepine Acetate

arrow
Fi Europe 2024
Not Confirmed

06

Brand Name : Aptiom

Eslicarbazepine Acetate

arrow
Fi Europe 2024
Not Confirmed

07

Brand Name : Aptiom

Eslicarbazepine Acetate

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Aptiom

arrow
Fi Europe 2024
Not Confirmed

Eslicarbazepine Acetate

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2016 Revenue in Millions : 92

2015 Revenue in Millions : 57

Growth (%) : 62

blank

08

Brand Name : Aptiom

Eslicarbazepine Acetate

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Aptiom

arrow
Fi Europe 2024
Not Confirmed

Eslicarbazepine Acetate

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2017 Revenue in Millions : 278

2016 Revenue in Millions : 199

Growth (%) : 40

blank

09

Brand Name : Aptiom

Eslicarbazepine Acetate

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Aptiom

arrow
Fi Europe 2024
Not Confirmed

Eslicarbazepine Acetate

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2018 Revenue in Millions : 178

2017 Revenue in Millions : 141

Growth (%) : 26%

blank

10

Brand Name : Zebinix

Eslicarbazepine Acetate

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Zebinix

arrow
Fi Europe 2024
Not Confirmed

Eslicarbazepine Acetate

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2017 Revenue in Millions : 49

2016 Revenue in Millions : 35

Growth (%) : 42

blank